CSIMarket
 


National Research Corporation  (NRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

NRC's Revenue Growth by Quarter and Year

National Research's Revenue results by quarter and year




NRC Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 38.30 34.77 32.62
III Quarter September 37.69 37.77 33.48 32.47
II Quarter June 37.29 36.43 31.17 31.41
I Quarter March 38.44 35.46 33.86 31.48
FY   113.42 147.96 133.28 127.98



NRC Revenue third quarter 2022 Y/Y Growth Comment
National Research Corporation reported decrease in Revenue in the third quarter 2022 by -0.21% to $ 37.69 millions, from the same quarter in 2021.
The decrease in the third quarter 2022 National Research Corporation's Revenue compares unfavorably to the Company's average Revenue growth of 1.51%.

Looking into third quarter 2022 results within Medical Laboratories industry 20 other companies have achieved higher Revenue growth. While National Research Corporation' s Revenue decline of -0.21% ranks overall at the positon no. 2033 in the third quarter 2022.




NRC Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 10.15 % 6.59 % 6.46 %
III Quarter September -0.21 % 12.81 % 3.11 % 8.2 %
II Quarter June 2.36 % 16.88 % -0.76 % 12.1 %
I Quarter March 8.4 % 4.73 % 7.56 % 1.48 %
FY   - 11.01 % 4.14 % 6.93 %

Financial Statements
National Research's third quarter 2022 Revenue $ 37.69 millions NRC's Income Statement
National Research's third quarter 2021 Revenue $ 37.77 millions Quarterly NRC's Income Statement
New: More NRC's historic Revenue Growth >>


NRC Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 1.4 % 3.85 % 0.46 %
III Quarter September 1.08 % 3.68 % 7.41 % 3.37 %
II Quarter June -2.99 % 2.74 % -7.94 % -0.22 %
I Quarter March 0.37 % 1.98 % 3.8 % 2.74 %
FY (Year on Year)   - 11.01 % 4.14 % 6.93 %




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #21
Healthcare Sector #306
Overall #2033

Revenue Y/Y Growth Statistics
High Average Low
4.4 % 1.51 % -0.75 %
(Sep. 30, 2013)   (Sep. 30, 2015)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #21
Healthcare Sector #306
Overall #2033
Revenue Y/Y Growth Statistics
High Average Low
4.4 % 1.51 % -0.75 %
(Sep. 30, 2013)   (Sep. 30, 2015)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

National Research's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
13.55 % 0.88 % -10.25 %
(Mar 31 2014)  


NRC's III. Quarter Q/Q Revenue Comment
National Research Corporation achieved in the III. Quarter 2022 above company average sequential Revenue growth of 1.08%, to $ 37.69 millions, from $37.29 millions in the second quarter.

Within Medical Laboratories industry 21 other companies have achieved higher Revenue quarter on quarter growth. While National Research's Revenue growth quarter on quarter, overall rank is 2146.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #22
Healthcare Sector #334
Overall #2146
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #22
Healthcare Sector #334
Overall #2146
Revenue Q/Q Growth Statistics
High Average Low
13.55 % 0.88 % -10.25 %
(Mar 31 2014)  


NRC's III. Quarter Q/Q Revenue Comment
National Research Corporation achieved in the III. Quarter 2022 above company average sequential Revenue growth of 1.08%, to $ 37.69 millions, from $37.29 millions in the second quarter.

Within Medical Laboratories industry 21 other companies have achieved higher Revenue quarter on quarter growth. While National Research's Revenue growth quarter on quarter, overall rank is 2146.


National Research's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 151.72 $ 151.80 $ 150.93 $ 147.95 $ 144.43
Y / Y Revenue Growth (TTM) 5.05 % 8.32 % 11.9 % 11.01 % 10.15 %
Year on Year Revenue Growth Overall Ranking # 1705 # 2188 # 1552 # 1541 # 1754
Seqeuential Revenue Change (TTM) -0.05 % 0.57 % 2.01 % 2.44 % 3.06 %
Seq. Revenue Growth (TTM) Overall Ranking # 2033 # 1588 # 1550 # 1368 # 2132




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, National Research's cumulative twelve months Revenue were $ 152 millions, company would post below average annual Revenue growth of 3.06% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the National Research's Revenue growth from the 37.29% growth in Jun 30 2022.

In the Healthcare sector 250 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1705, from total ranking in previous quarter at 2188.

Revenue TTM Q/Q Growth Statistics
High Average Low
4.4 %
1.51 %
-0.75 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 21
Healthcare Sector # 251
Overall # 1705

Revenue TTM Y/Y Growth Statistics
High Average Low
118.25 %
15.5 %
3.47 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 306
S&P 500 # 2033
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, National Research's cumulative twelve months Revenue were $ 152 millions, company would post below average annual Revenue growth of 3.47% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the National Research's Revenue growth from the 37.29% growth in Jun 30 2022.

In the Healthcare sector 250 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1705, from total ranking in previous quarter at 2188.

Revenue TTM Q/Q Growth Statistics
High Average Low
4.4 %
1.51 %
-0.75 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 21
Healthcare Sector # 251
Overall # 1705

Revenue TTM Y/Y Growth Statistics
High Average Low
118.25 %
15.5 %
3.47 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 306
S&P 500 # 2033




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NRC's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NRC's Competitors
Revenue Growth for National Research's Suppliers
Revenue Growth for NRC's Customers

You may also want to know
NRC's Annual Growth Rates NRC's Profitability Ratios NRC's Asset Turnover Ratio NRC's Dividend Growth
NRC's Roe NRC's Valuation Ratios NRC's Financial Strength Ratios NRC's Dividend Payout Ratio
NRC's Roa NRC's Inventory Turnover Ratio NRC's Growth Rates NRC's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc -0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Syneos Health Inc -0.89%$ -0.891 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corp-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions
Lifevantage Corp-2.72%$ -2.724 millions
West Pharmaceutical Services Inc -2.77%$ -2.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PTWOU's Profile

Stock Price

PTWOU's Financials

Business Description

Fundamentals

Charts & Quotes

PTWOU's News

Suppliers

PTWOU's Competitors

Customers & Markets

Economic Indicators

PTWOU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071